MyMetabolon Login
© 2021 Metabolon, Inc. All rights reserved.
Metabolon Metabolon
  • Metabolomics
    • About Metabolomics
    • Our Process
    • Technology & Knowledgebase
    • Quality Assurance
    • Setting the Standard: The 4Cs
    • Our Latest Insights
  • Solutions
    • Column 1
      • Products & Services
        • Global Metabolomics
        • Lipidomics
        • Targeted Assays
        • Microbiome
        • Study Design & Consulting
        • Sample Preparation & Handling
        • Study Success Sample Handling Kit
        • Reporting & Interpretation
        • Bioinformatics
        • MyMetabolon Client Portal
    • Column 2
      • By Research & Development Phase
        • Discovery & Target Selection
        • Lead Candidate Selection
        • Preclinical
        • Clinical Development
        • Manufacturing & Bioprocessing
    • Column 3
      • By Therapeutic Area
        • Cardiovascular Disease
        • COVID-19
        • Diabetes
        • Gastrointestinal
        • Liver Disease
        • Neuroscience
        • Oncology
        • Renal & Urological Disorders
        • Respiratory Disorders
    • Column 4
      • By Sector
        • Academic
        • Agriculture
        • Biotech / Pharmaceutical
        • Precision Medicine
        • Nutrition
        • Personal Care & Cosmetics
        • Population Health
        • Veterinary & Animal Health
  • Insights
    • Our Latest Insights
    • Blog
    • News & Events
    • Publications
  • Resources
    • Resource Library
    • Client Stories
    • COVID-19
    • Publications
  • Company
    • About Us
    • Working With Us (FAQ)
    • Leadership
    • Careers
    • Strategic Partnering
    • News & Events
    • Contact Us
MyMetabolon
Demo Our Data
Metabolon
Demo Our Data
DBS Validation and Platform Combo_December2020 (NYU Webinar)_CJW

Webinar • Video

Dried Blood Spot (DBS) Card Analysis on Metabolon’s Precision Metabolomics™ Platform

The consensus is clear: metabolomic data can play a pivotal role in understanding key questions across the life sciences. For example, in population health, metabolomics is increasingly viewed as a robust phenotyping tool with the power to link genomic and transcriptomic variation on the one hand with clinical outcomes on the other hand. Likewise, in drug development, metabolomics offers a vast trove of potential biomarkers for monitoring disease progression, drug efficacy, and both on- and off-target toxicity.

Metabolon has always sought to deliver innovative solutions and support each client’s key research objectives by addressing common pain points and overcoming previous pitfalls of metabolomic analysis. Recently, our efforts to broaden metabolomics access and utility reached a new level through the expansion of our support to include dried blood spot (DBS) card samples.

This validated solution provides researchers with an alternative solution when access to, or appropriate storage and handling of, blood plasma and/or serum is limited or not possible.

Metabolon experts provide an overview of Metabolon’s Precision MetabolomicsTM platform and a deeper dive into the extensive validation work that was conducted in dried blood spot (DBS) samples.

Watch this on-demand event to:
• Explore the benefits of adding metabolomics to your research
• Hear about the biological and analytical findings from the DBS sample validation
• Discover the benefits of DBS samples

Watch the Video
Back to Resource Library
  • Unique advantages of incorporating untargeted and targeted metabolomics in drug development and Clinical Trials (EPR)
    Previous ProjectUnique advantages of incorporating untargeted and targeted metabolomics in drug development and Clinical Trials (EPR)
  • Next ProjectIntegration of Multi-Omic Technologies Driving Microbiome Research
    Unique advantages of incorporating untargeted and targeted metabolomics in drug development and Clinical Trials (EPR)

Metabolomics

  • About Metabolomics
  • Our Process
  • Technology & Knowledgebase
  • Quality Assurance
  • Setting the Standard: The 4Cs
  • Insights & Discoveries

Solutions

  • Products & Services
  • By Research & Development Phase
  • By Therapeutic Area
  • By Sector

Insights

  • Our Latest Insights
  • Blog
  • News & Events
  • Publications

Resources

  • Resource Library
  • Client Stories
  • COVID-19

Company

  • About Us
  • Working With Us (FAQ)
  • Leadership
  • Careers
  • Strategic Partnering
  • News & Events
  • Contact Us
Metabolon - Logo - Enlightening Life

Metabolon provides actionable biological insights to answer the toughest questions in life sciences research and drug development.

© 2022 Metabolon, Inc. All rights reserved. Privacy & Terms

in
Copy